A Study to Determine if Ibuprofen in Combination With Pseudoephedrine HCl is More Effective Than Each Drug Alone in the Treatment of Nighttime Bedwetting
A Comparative Study of Coadministered Doses of Ibuprofen and Pseudoephedrine HCl and Each Drug Alone in the Treatment of Primary Nocturnal Enuresis in Children
1 other identifier
interventional
318
0 countries
N/A
Brief Summary
The purpose of the study is to determine if ibuprofen in combination with pseudoephedrine HCl in the treatment of nightime bedwetting in children is more effective than each drug alone and if the individual drugs are more effective than placebo.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Completion
Last participant's last visit for all outcomes
November 1, 2002
CompletedFirst Submitted
Initial submission to the registry
October 14, 2005
CompletedFirst Posted
Study publicly available on registry
October 18, 2005
CompletedJune 29, 2011
June 1, 2011
October 14, 2005
June 28, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The mean reduction in wet nights from the 14-day baseline period to the 14-day treatment period.
Secondary Outcomes (1)
The proportion of subjects with at least a 50% reduction in wet nights from baseline; the mean number of wet nights during the 14 days of treatment.
Interventions
Eligibility Criteria
You may qualify if:
- Subject has nighttime bedwetting
- between the 5th and 95th percentiles for weight based on age and gender
- has a minimum of eight wet nights per 14 days of the baseline period
- healthy with no symptoms of any other complicating disease as determined by medical history review, physical examination, and clinical laboratory tests.
You may not qualify if:
- Subject has daytime urinary incontinence or abnormal bowel habits (i.e. fecal incontinence or constipation)
- has had episodes of dryness lasting one month or longer, at any time in the past
- has a medical condition which may be relevant to participation in the study
- has a known sensitivity or allergy to the study medications.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Caldwell PH, Codarini M, Stewart F, Hahn D, Sureshkumar P. Alarm interventions for nocturnal enuresis in children. Cochrane Database Syst Rev. 2020 May 4;5(5):CD002911. doi: 10.1002/14651858.CD002911.pub3.
PMID: 32364251DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
McNeil Consumer & Specialty Pharmaceuticals, a Division of Mc Neil-PPC, Inc. Clinical Trial
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
October 14, 2005
First Posted
October 18, 2005
Study Completion
November 1, 2002
Last Updated
June 29, 2011
Record last verified: 2011-06